Whole-Body MRI Screening and Anxiety: Patient Experience and Long Term Effects

1. Anxiety and Whole-Body MRI in Preventive Screening

Alongside interest in clinical yield, clinicians and policy commentators frequently raise concerns about patient anxiety as a potential downside of screening with whole-body MRI. In practice, however, anxiety is often discussed as a single, uniform outcome, without separating anticipatory worry before testing, situational distress during the exam, and results-related uncertainty after the scan. 

‍

The real question is not whether any patient ever feels anxious around whole-body MRI; medical anxiety occurs around many tests and even standard encounters, such as screening mammography, colonoscopy, or a routine periodic health checkup at a healthcare practitioner’s office, as reflected in the phenomenon of “white coat syndrome”. Rather, the question is whether the screening process is associated with sustained anxiety or clinically meaningful deterioration in psychological well-being. If anticipated anxiety alone should not be enough to avoid those screening practices, then by extension it should not end considerations for screening WB-MRI either. We aim to review the sources and timing of anxiety around whole‑body MRI, summarize evidence on long-term anxiety associated with screening, and outline what practical steps make the screening more predictable and supportive for the patient.

2. Pre-Scan Concerns and Expectations

Pre-scan anxiety most often centers on three issues: what the scan might reveal, how to interpret unexpected findings, and whether the MRI itself will be tolerable. Many patients also feel ambivalent about screening itself, wanting the reassurance of information while fearing what they might learn if something is wrong. Incidental findings unrelated to symptoms are often benign, but patients who are unfamiliar with medical terminology or clinical risk stratification may interpret even benign results as threatening before they are explained in context and paired with a clear follow-up plan.¹

‍

Providers can reduce worry that builds as patients think ahead by making the process predictable and shared. A helpful approach is to review in advance how different categories of results are handled and to decide together what follow-up would look like in each case. This shared decision-making gives patients agency. Across 81,786 Prenuvo scans conducted between January 2024 and June 2025, a total of 1,121,380 findings were identified, the majority of which were not clinically concerning. Specifically, 92% were classified as CSD-1 or CSD-2—of no clinical significance in the typical asymptomatic screening setting. A further 7.4% were CSD-3 findings, which are generally low concern but may warrant clinical awareness, discussion, or contextualization depending on an individual’s history, risk factors, or preventive care considerations. Only 0.4% of findings were classified as CSD-4 or CSD-5, representing findings that directly warrant diagnostic evaluation, specialist consultation, or, in rare cases, expedited medical attention. This structured stratification helps contextualize results at a glance—making clear that most findings are inherently low-risk, while ensuring that the small minority requiring action can be identified and prioritized without delay.

Clear, timely communication reduces MRI-related anxiety because it replaces open-ended possibilities with defined options and a known path to interpretation. Lastly, a specific plan for result timing and review is part of expectation-setting, because uncertainty about when and how results will be discussed can become an important source of pre-scan anxiety.

‍

3. In-Scan Experience: Comfort and Control During the Scan

Procedural expectations matter as much as diagnostic expectations. Claustrophobia, being inside the MRI bore, noise, and the requirement to remain immobile commonly drive anxiety even in patients who are otherwise comfortable with medical testing. Reviewing what the scan environment is like, how patients can communicate with the team during the exam, and what options exist if anxiety rises can prevent anticipatory fear from becoming the main experience of the visit.^2-3

‍

Comfort planning can reduce anxiety about being inside the machine, especially claustrophobia and sensitivity to noise. In our experience at Prenuvo, these concerns are often manageable with scanners that have wider bore openings than traditional narrow-bore or closed-bore systems, which can lessen the sense of confinement.⁴ Open communication with the technologist can further relieve stress, as the technologist can check in regularly, provide timing updates, make minor comfort adjustments when needed, and respond immediately if the patient reports pain, discomfort, or escalating anxiety. Patients also benefit from options that occupy attention during the exam, such as streaming personalized video and audio content.⁵ 

‍

Physical comfort also affects emotional comfort. Positioning, padding, temperature, and pain-related concerns can meaningfully change the experience, particularly for patients with back pain, shoulder issues, or difficulty lying flat. Addressing these needs in advance and normalizing them as common can prevent discomfort from escalating into anxiety. Furthermore, when clinically appropriate, patients undergoing WB-MRI may be offered a one-time mild sedative or anti-anxiety medication to improve comfort and cooperation. Furthermore, optimizing patient comfort also, improves image quality by reducing the likelihood of motion artifacts.¹⁴ When the environment is explained, communication is available, and comfort is actively managed, anxiety during the scan is often situational, significantly mitigated in intensity, and resolves once the scan is complete.⁶

‍

4. Between Scan and Results

For some patients, anxiety decreases once the scan is complete. The apprehension related to the procedure itself is over, and there is relief in having taken action. For others, however, anxiety shifts rather than resolves. The focus moves from tolerating the scan to anticipating the results. Individual differences play a significant role at this stage. Patients who are generally comfortable with uncertainty may experience the waiting period as neutral and get back to routine quickly, while those with higher baseline health anxiety or prior negative medical experiences may find this interval more emotionally demanding.⁷

‍

When anxiety does arise, it often shows up as rumination, repeated checking, and worst-case thinking. Some patients may revisit what the scan might show or reinterpret benign bodily sensations as potential symptoms. This is not inevitable, and it is often manageable when the process is structured. Clear expectations about when results will be available, how they will be reviewed, and what happens if follow-up is recommended can contain worry by keeping the waiting period from feeling open-ended. Practical guidance on what is normal to feel while waiting, and when to reach out with questions, can also reduce escalation.

‍

Anxiety during this phase does not necessarily translate into long-term psychological burden. For many patients, worry peaks while results are pending and declines once findings are explained and placed in context.⁶ When results are reviewed in a way that connects findings to clinical relevance and next steps, uncertainty is reduced and patients commonly return to baseline. In this sense, the waiting period is often a temporary adjustment rather than a sustained source of distress.

‍

5. After Results: Understanding and Next Steps

Responses vary depending on the type of result and the patient’s baseline tolerance for uncertainty. Patients often experience immediate relief when no concerning findings are identified. Nonetheless, others may feel a temporary increase in anxiety if follow-up is recommended, even when the clinical risk is low. What consistently moderates this response is interpretation, contextualization, and appropriate clinical counseling. Results delivered without context can amplify concern, whereas results reviewed in a clinical framework, including what the finding means, what it does not mean, and what happens next, tend to limit unnecessary intensification of worry and help patients make informed choices about follow-up. 

‍

Importantly, available evidence suggests that anxiety after whole-body MRI is usually time-limited.⁸ Once findings are explained and a plan is in place, most patients return to baseline levels of concern. The shift from uncertainty to structured action often reduces worry rather than sustaining it.⁹ In a study assessing the psychosocial effects of multi-organ screening in TP53 mutation carriers, who are at genetically increased risk of developing cancer during their lifetimes, anxiety was highest before the WB-MRI and significantly decreased 2 weeks after the scan, suggesting that receiving scan results provides reassurance and psychological benefit independent of any effect on cancer morbidity and mortality associated with this genetic condition.¹³ Persistent distress is uncommon and more strongly associated with pre-existing anxiety than with the scan itself.

‍

A distinct concern in screening is the fear of a potentially-concerning screening result in an otherwise asymptomatic person. When a clinically meaningful finding is identified, the initial emotional impact can be significant, particularly because it occurs in the absence of symptoms and may feel unexpected. At the same time, screening findings are often detected at an earlier, more effectively actionable and less disruptive stage than symptom-prompted diagnosis, which can shift the experience from fear toward a sense of direction and control.¹⁰ Patients are no longer managing an abstract possibility; they are working with specific information and a plan. Patients, including those with findings that prompt follow-up, do not generally experience long-term regret; once results are explained and an actionable plan is in place, they commonly feel reassured despite initial distress.¹⁰

‍

6. What the Literature Reports on Long-term Anxiety Around Whole-Body MRI

In a study, based on the SHIP-TREND population cohort, investigators examined whether undergoing whole-body MRI and receiving potentially concerning findings would have lasting psychological consequences. Because approximately one-third of participants were informed of potentially concerning findings and some reported short-term distress, there was concern that screening might negatively affect longer-term well-being. However, longitudinal follow-up at approximately 2 to 3 years showed no meaningful differences in physical quality of life, psychological quality of life, or depressive symptoms between those who underwent MRI and those who did not. Importantly, there were also no sustained differences between participants who received findings and those who did not.¹¹ These results suggest that although potentially concerning findings can generate temporary anxiety, disclosure within a structured research setting did not translate into measurable long-term deterioration in quality-of-life or depression indicators.

‍

Similarly, in a case-control study it was found that potentially concerning findings did not meaningfully worsen psychological outcomes.¹² Only a small number of participants felt extra stress while waiting for their results, and overall stress levels were similar before the scan and after results were received. Among those who had potentially concerning findings, most described the information as helpful, while only a few found it highly burdensome. Participants also strongly preferred to be told about incidental findings, and this preference increased over time, even for findings considered less clinically important. Finally, receiving an incidental finding was not linked to higher rates of moderate or severe depressive symptoms after the scan. Overall, these results suggest that clear, standardized reporting of incidental findings can match patient preferences without causing major psychological harm.

‍